跳轉至內容
Merck
  • Protocol for using heterologous spike-ins to normalize for technical variation in chromatin immunoprecipitation.

Protocol for using heterologous spike-ins to normalize for technical variation in chromatin immunoprecipitation.

STAR protocols (2021-07-01)
Franziska Greulich, Aikaterini Mechtidou, Teresa Horn, Nina Henriette Uhlenhaut
摘要

Quantifying differential genome occupancy by chromatin immunoprecipitation (ChIP) remains challenging due to variation in chromatin fragmentation, immunoprecipitation efficiencies, and intertube variability. In this protocol, we add heterologous spike-ins from Drosophila chromatin as an internal control to the mice chromatin before immunoprecipitation to normalize for technical variation in ChIP-qPCR or ChIP-seq. The choice of spike-in depends on the evolutionary conservation of the protein of interest and the antibody used. For complete details on the use and execution of this protocol, please refer to Greulich et al. (2021).

材料
產品編號
品牌
產品描述

Roche
不含EDTA的cOmplete Mini蛋白酶抑制剂混合物, Protease Inhibitor Cocktail Tablets provided in a glass vial, Tablets provided in a glass vial
Sigma-Aldrich
甘氨酸, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
水, BioPerformance Certified
Sigma-Aldrich
Octoclothepin 马来酸盐, solid